Neuropace, Inc. NPCE Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $21.81M+61.0% | $13.55M-25.5% | $18.18M+170% | $6.73M-65.2% | ||
| $39.37M+0.1% | $39.33M-18.7% | $48.4M-31.6% | $70.8M-26.5% | ||
| $58.61M+23.9% | $47.29M+8.3% | $43.66M+32.7% | $32.89M+11.1% | ||
| $64.96M+34.6% | $48.24M+15.6% | $41.74M+19.9% | $34.82M+20.1% | ||
| $94.07M+15.7% | $81.34M-12.3% | $92.72M-5.1% | $97.71M-26.4% | ||
| $1.13M+6.9% | $1.05M+4.9% | $1M-5.7% | $1.06M+76.5% | ||
| $105.57M+11.5% | $94.65M-12.1% | $107.65M-5.7% | $114.11M-14.6% | ||
| $15.57M+45.9% | $10.67M+48.7% | $7.18M+1.7% | $7.05M+38.7% | ||
| $141K-74.6% | $555K-49.1% | $1.09M— | $0— | ||
| $17.81M+17.5% | $15.16M-6.6% | $16.23M+47.9% | $10.98M+18.0% | ||
| $58.88M-1.1% | $59.53M+4.5% | $56.95M+7.6% | $52.91M+6.2% | ||
| $0— | $0— | $0— | $0— | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$552.42M-4.0% | -$530.95M-5.4% | -$503.81M-7.0% | -$470.85M-11.1% | ||
| $19.03M+138% | $8.01M-61.2% | $20.65M-40.6% | $34.78M-52.7% | ||
| $105.57M+11.5% | $94.65M-12.1% | $107.65M-5.7% | $114.11M-14.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Neuropace, Inc.'s total assets?
- Neuropace, Inc. (NPCE) holds $98.9M in total assets, down 10.3% year over year.
- How much debt does Neuropace, Inc. have?
- Neuropace, Inc. carries $70.5M in total debt against $14.5M of shareholders' equity, a debt-to-equity ratio of 4.87.
- How much cash does Neuropace, Inc. have?
- Neuropace, Inc. holds $15.6M in cash and equivalents.
- Can Neuropace, Inc. cover its short-term obligations?
- Its current ratio is 5.38 — current assets exceed current liabilities.
- Where does Neuropace, Inc.'s balance sheet data come from?
- Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
